Global representativeness and impact of funding sources in cost-effectiveness research on systemic therapies for advanced breast cancer: A systematic review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Global representativeness and impact of funding sources in cost-effectiveness research on systemic therapies for advanced breast cancer: A systematic review

Published:2024-06 Issue: Volume:75 Page:103727
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Lazar Neto Felippe^ORCID,de Melo Marina Acevedo Zarzar,Hidalgo Filho Cassio Murilo Trovo^ORCID,Mathias-Machado Maria Cecília^ORCID,Testa Laura,Campolina Alessandro Gonçalves^ORCID

Publisher

Elsevier BV

Reference26 articles.

1. The ever‐increasing importance of cancer as a leading cause of premature death worldwide;Bray;Cancer,2021

2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

3. An updated profile of the cancer burden, patterns and trends in Latin America and the Caribbean;Piñeros;Lancet Reg Health - Am,2022

4. Cancer statistics, 2023;Siegel;CA Cancer J Clin,2023

5. Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050;Chen;JAMA Oncol,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP